Abrdn PLC Krystal Biotech, Inc. Transaction History
Abrdn PLC
- $57.3 Billion
- Q2 2025
A detailed history of Abrdn PLC transactions in Krystal Biotech, Inc. stock. As of the latest transaction made, Abrdn PLC holds 108,518 shares of KRYS stock, worth $15 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
108,518
Previous 37,301
190.93%
Holding current value
$15 Million
Previous $6.73 Million
121.8%
% of portfolio
0.03%
Previous 0.01%
Shares
6 transactions
Others Institutions Holding KRYS
# of Institutions
329Shares Held
24.4MCall Options Held
299KPut Options Held
97.6K-
Black Rock Inc. New York, NY3.95MShares$547 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.82MShares$391 Million0.01% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.73MShares$379 Million7.97% of portfolio
-
State Street Corp Boston, MA1.23MShares$170 Million0.01% of portfolio
-
Capital World Investors Los Angeles, CA954KShares$132 Million0.03% of portfolio
About Krystal Biotech, Inc.
- Ticker KRYS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,664,300
- Market Cap $3.56B
- Description
- Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing ...